Destination therapy: Safety and feasibility of national and international travel

Results for Destination Therapy (DT) continue to improve with advanced technology, better patient selection, and experienced clinical management. Quality of life for these patients is an important component of the overall success of DT, and traveling is becoming more common. We reviewed our experience with long-distance travel in our DT population. All patients implanted with a left ventricular assist device for DT were followed prospectively. Long-distance travel was considered to be >200 miles, one way from their homes. There were 15 patients (14 men) with an average age of 66 years (range, 30-82) who traveled a combined total of 40 long-distance trips. Four trips were international (Spain, Canada (2), and Puerto Rico), 35 within the continental U.S., and one to Hawaii. The average one way distance traveled was 925 miles with a range of 218-4256 miles. The average time away from home was 8.3 days (range, 2-30). Patients traveled by airplane (17), car (23), and one trip included a 5 day cruise. Five complications occurred: driveline trauma, delay of reentry into the United States, missed flight, red heart alarm from bearing wear, and dehydration. All patients returned home safely for routine follow-up. Long-distance travel is possible for DT patients. Anticipating potential problems and careful planning is necessary for safe national and international travel.